Skip to main content
IPAR logo

IPAR · Interparfums Inc

Track IPAR — free
$111.30 -3.79 (-3.29%) At close · Sep 30
Market Cap
$3.78B
Shares
32.03M
Volume · Sep 30 290.29K Avg daily vol (3M) 262.21K

Price & Indicators

Drag to pan · scroll to zoom
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$115.09 Open$117.35 Day$114.73–117.75 52W close$79.57–128.55 Avg vol 30d215K Short int2.1M · 6.5% float · 11.3d Short vol44% Last earningsAug 5, 2026 DataJan 2020–Sep 2026 Filing10-Q · Aug 4

Up next

Next earnings call
Nov 3, 2026 Est · unconfirmed · in 5 wks
filed Aug 4, 2026
call held Aug 5, 2026

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
$1.50B
Trailing 12 months
Net income (TTM)
$167.76M
Trailing 12 months
Revenue growth YoY
+2.1%
Year over year
Operating margin
17.3%
Trailing 12 months
P / E (TTM)
22.0
Trailing earnings · reciprocal yield 4.5%
FCF yield
6.5%
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
$12.76M
Latest balance sheet
Dividend yield
2.8%
Trailing 12 months
Shares change YoY
-0.4%
Year over year · fewer shares
Price change (1Y)
+14.8%
Trailing year
Short interest
6.5%
Latest settlement · 11.3 days to cover
View all 115 metrics

AI Brief

Q2 FY26 earnings call · Aug 5, 2026
Q2 FY26

TL;DR. Interparfums reported 2% consolidated sales growth in Q2 and H1 2026 (to $341M and $686M), maintained its full-year guidance of ~$1.48B sales and $4.85 EPS, received $17.6M in IEPA tariff refunds boosting gross margin outlook by ~150 bps, and is preparing an unusually heavy slate of blockbuster fragrance launches across major brands for 2027 alongside the rollout of new Longchamp and Off-White licenses.

Bullish
  • + IEPA tariff refunds of $17.6M, with $8.7M received including a $6.9M non-recurring cost-of-sales benefit in Q2, are expected to drive ~150 bps of full-year gross margin expansion.
  • + U.S.-based operations sales jumped 18% in Q2 and 10% in H1, with operating margin expanding as SG&A grew slower than sales.
  • + Operating cash flow surged to $46M in H1 (49% of net income) from $5M (5%) last year, supported by working capital improvements and a 34-day reduction in inventory days.
  • + First half 2026 gross margin expanded 30 bps to 65.3% and the top 20 brand-region combinations grew a healthy 7%.
  • + A broad slate of blockbuster launches is lined up across all $100M+ brands for 2027, with Longchamp seen as a potential next $100M brand and first launches of Off-White planned for late Q1 2027.
Bearish
  • − Operating margin compressed to 17.9% in H1 2026 from 20% in the prior-year period as A&P spend rose to 18.8% of sales.
  • − European-based sales fell 4% in Q2 and 1% in H1, with operating margin on European net sales dropping to 10% from 13.6% in Q2.
  • − The war in the Middle East and Africa caused a 24% regional sales decline and represented a 3% Q2 / 2% H1 consolidated headwind.
  • − Lacoste sales declined 19% in Q2 and 16% in H1 against very tough comparisons, with Eastern Europe also down 7%.
  • − H1 2026 net income was flat at $74M and diluted EPS was essentially unchanged at $2.31 vs $2.32, with guidance implying a 3% H2 sales decline versus prior year.

AI-generated from the earnings call and 8-K · may contain errors · not investment advice

Equibles Rating

blended score · not investment advice
Overall
Buy
SellHoldBuy
Technical Buy Momentum Very Strong Sentiment Neutral Fundamentals Excellent Quant / Vol Moderate
Market backdrop VIX 16 · calm Equity put/call 0.38
Technical
price trend
Buy
50 / 200-day cross No cross
Price vs 200-day avg +14%
above
Price vs 50-day avg −2%
below
RSI (14) 50
neutral
MACD trend Positive
52-week position 73%
mid-range
Momentum
relative strength
Very Strong
1-month return −2%
trailing
6-month return +27%
trailing
YTD return +36%
this year
Relative strength +14%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50d $118 › 200d $101 — 50d above 200d
Institutional flow Accumulating
+1% holders QoQ · +42 funds added
Insider flow Distributing
Net -$105.2K over 90 days · 100% sells
Short interest Rising
6.52% of float · ▲ +7.2% MoM · 11.3 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
316 holders — near 3-yr high, broad support
Squeeze score 70
elevated · 0–100
Fundamentals
Excellent
Revenue growth +21%
Y/Y
Gross margin 72%
contracting
EPS growth +2%
Y/Y
Free cash flow $190.5M
Valuation P/E 22.6
below peers
Quant / Vol
risk profile
Moderate
Volatility 31%
annualized · 1-yr
Max drawdown −21%
past year
ATR 3.0%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

Beat or met 1 of last 2
Latest guidance · from the Earnings Call filed Aug 5, 2026
Sales · full-year 2026 Initiated $1.48B
prior FY $1.49B midpoint −0.6% Y/Y
Guided vs delivered · last 2 settled
Net sales full year 2024
guided $1.45B
$1.45B Beat +0.2%
Earnings per diluted share full year 2024
guided $5.15
$5.12 Miss −0.6%

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Buy
0 · 4 · 2
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
+14% Bullish
Price vs 50-day avg
−2% Neutral
RSI (14)
50 Neutral
MACD trend
Positive Bullish
52-week position
73% Neutral
Market signals — smart money & positioning
Mixed
Trend (MA cross) No cross
50d $118 › 200d $101 — 50d above 200d
Institutional flow Accumulating
+1% holders QoQ · +42 funds added
Insider flow Distributing
Net -$105.2K over 90 days · 100% sells
Short interest Rising
6.52% of float · ▲ +7.2% MoM · 11.3 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
316 holders — near 3-yr high, broad support
Price context
position in its 52-week range
Range low $80 Now $115 · 73% Range high $129
vs 200-day avg +14% vs 50-day avg -2%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

Earlier KPI extraction records exist, but do not meet the current evidence-completeness requirements. No current verified series is available. Earlier figures remain withheld until revalidated; this is not evidence that the company reports no KPIs.

Versus peers

Household & Personal Products — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
IPAR
Interparfums Inc
this stock
$3.78B +35.7% +21.3% 22.6 6.5%
PG
PROCTER & GAMBLE Co
$339.90B +3.5% +3.3% 22.1 1.0%
UL
Unilever PLC
$134.67B -6.4% — — 0.2%
CL
Colgate Palmolive Co
$69.13B +9.4% +1.7% 34.3 2.3%
RBGLY
Reckitt Benckiser Group PLC
$41.79B — — — 0.0%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Accumulating
Holders
316
% held
67.2%
Net QoQ
+731.9K sh
Top holder
BlackRock, Inc.
Held Float
View
Held by Funds
Fund positions
326
View
Short & Settlement
Short Interest Rising
Shares short
2.1M
Days to cover
11.3d
Change
+140.6K sh
View
Short Volume
Short vol %
44%
As of
Sep 30, 2026
Short Total
View
Fails to Deliver
FTD shares
491
Value
$55.0K
As of
Sep 14, 2026
View
Off-Exchange
Off-exchange %
44.9%
Week of
Aug 24, 2026
Off-exch Lit
View
Smart Money
Insider Trades Net selling
Net (90d)
-$105.2K
Buyers / Sellers
0 / 1
Buyers Sellers
View
Financials
Financials
Revenue (FY)
$1.3B
Net income (FY)
$168.4M
EPS diluted
$5.24
View
Buybacks
Authorized
shares 260.0K
View
Filings
SEC Filings
Latest
8-K
Filed
Sep 22, 2026
This year
17
View
Proposed Sales
Value
$105.2K
Shares
900
Filed
Aug 27, 2026
View
Earnings & Events
Earnings Calls
Last call
Aug 5, 2026
View

Performance

5D 20D 120D MTD YTD
IPAR -2.7% -2.0% +27.1% -2.0% +35.7%
SPY -1.2% -0.4% +13.1% -0.4% +12.1%
vs SPY -1.5% -1.6% +14.1% -1.6% +23.6%

Capital returns

Latest dividend
$0.80 / share · ex Sep 15, 2026
Raised 6.7%
Paid (TTM)
$3.20 / share · 4 payouts
Dividend yield (TTM, derived)
2.78%
Buyback program · as of Apr 30, 2025
Authorized
shares 260,000
Spent (derived)
—
Remaining
—

Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

Key facts CIK 822663 CUSIP 458334109 13F (30d) 6 filings 6 filers Visit website Investor relations